Project Details
Description
This is a phase II, multi-center study of IV Tirapazamine plus Cisplatin in patients with non-small cell lung cancer (NSCLC) to estimate the rate of objective tumor response to tirapazamine when administered intravenously in combination with cisplatin; to estimate time to disease progression; and to assess the safety of the combined treatment regimen in this population.
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/95 → 9/30/96 |
Funding
- National Center for Research Resources
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.